MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Parkinson’s"

  • 2025 International Congress

    Quality of Life of Parkinson’s Disease Patients in the Thai Population: A Cross-Sectional Analysis

    C. Ounmuang, S. Rujirussawarawong, N. Limotai, S. Aungsumart, C. Kasemsuk (Bangkok, Thailand)

    Objective: Primary: To assess QoL in PD patients at the Neurological Institute of Thailand (NIT).Secondary: To identify clinical factors associated with QoL. Background: Parkinson’s disease…
  • 2025 International Congress

    Negative Correlation between Apathy and Executive Functioning in Patients with Idiopathic Parkinson’s Disease without Dementia.

    P. Andrea Gutiérrez-Lenis, C. Alberto Hurtado-González, J. Felipe Ayala-Rico, S. Ospinta-Otalvaro, A. Lucumi-Moreno, M. Cañas-Lucendo, D. Reyes-Torres, S. Ordoñez-Cure, A. Cubides-Munévar, A. Maria Valencia-Orjuela (Cali, Colombia)

    Objective: To establish the impact of apathy on executive functioning in patients with IPDWD. Background: Executive Functioning is one of the domains of neurocognitive functioning…
  • 2025 International Congress

    Modeling Inflammation in GBA-Associated Parkinson’s Disease: Insights into Disease Mechanisms

    V. Lentini, G. Uras, S. Lucas, D. Moreno-Martinez, A. Manca, F. Fierli, S. Koletsi, A. Pantaleo, D. Hughes (Sassari, Italy)

    Objective: This investigation centers on the role of inflammation in GBA-associated Parkinson’s disease (PD), a neurodegenerative disorder characterized by the progressive degeneration of dopaminergic neurons,…
  • 2025 International Congress

    Cell-type specific bidirectional modulation of STN neurons rescue Parkinsonian motor symptom.

    JH. Shin, HK. Chung, JH. Kim, JS. Yook, J. Kim, B. Jeon (Seoul, Republic of Korea)

    Objective: This study aimed to identify the specific STN cell type and circuit responsible for alleviating parkinsonian motor symptoms through targeted neural modulation. Background: The…
  • 2025 International Congress

    Mass spectrometry-based screening for α-synuclein bioactive marine natural products

    F. Ferretti, M. Xu, D. Prebble, G. Mellick, A. Carroll (Gold Coast, Australia)

    Objective: This study identifies marine-derived natural products with binding affinity and aggregation-inhibition activity against α-synuclein (α-syn) using a mass spectrometry (MS)-based screening approach. The objective…
  • 2025 International Congress

    Characterising Peripheral Innate Immune Cell Infiltration into the Brain in Parkinson’s Disease

    C. Tournerie, B. Patel, A. Quaegebeur, C. Williams-Gray (Cambridge, United Kingdom)

    Objective: To characterise the infiltration of peripheral innate immune cells (NK cells, monocytes and neutrophils) into the brain in Parkinson’s disease (PD) and to investigate…
  • 2025 International Congress

    Dopaminergic and Synaptic Alterations in SWEDD: Insights from [¹⁸F] FE-PE2I and [¹¹C] UCB-J PET Imaging

    F. Ebrahimian Sadabad, T. Volpi, P. Honhar, L. Colon, S. Tinaz, M. Naganawa, M. Dias, G. Angarita, R. Comley, R. Carson, S. Finnema, D. Matuskey (Tallahassee, USA)

    Objective: To investigate dopaminergic and synaptic density in SWEDD patients compared to idiopathic Parkinson’s disease (IPD) and healthy controls (HCs). Background: Scans Without Evidence of…
  • 2025 International Congress

    Evaluation of swallow tail sign on 1.5 Tesla Magnetic Resonance Imaging in Parkinson´s disease patients in a tertiary hospital

    E. Vioncek, M. Ferreira Cordellini, L. Kami, B. Teixeira (Curitiba, Brazil)

    Objective: To evaluate the swallow tail sign in 1.5 Tesla magnetic resonance imaging (MRI) scans of patients diagnosed with Parkinson's disease (PD). Background: Nigrosome-1 appears…
  • 2025 International Congress

    Mining Metabolomics GWAS for Key Parkinson’s Disease Variants: A Bioinformatics Approach to Genetic-Metabolic Associations

    S. Rodríguez-Quiroga, T. Ascencio, J. Largo Gonzalez, S. Peña Martinez, L. Hernandez Delgado, A. Noyce, M. Tan (Buenos Aires, Argentina)

    Objective: To propose a novel approach to explore genetic-metabolic interactions in Parkinson’s disease (PD) by integrating the largest genome-wide association studies (GWASs) for PD and…
  • 2025 International Congress

    Inflammatory profile in LRRK2-associated prodromal and clinical PD:a cross-sectional study

    CC. Fan, JY. Liu, JH. Ma, XL. Liu, P. Chan, SY. Liu (Beijing, China)

    Objective: To investigate the peripheral inflammatory cytokine levels and their associations with clinical severity, dopaminergic presynaptic degeneration in asymptomatic carriers and PD patients with LRRK2 mutation.To investigate…
  • « Previous Page
  • 1
  • 2
  • 3
  • 4
  • 5
  • …
  • 436
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley